When looking at early-stage PBC, one study found enhanced secretin/SR expression in bile ducts of human samples and the dominant-negative TGF-β receptor II mouse model of PBC (Kennedy et al., 2019). This evidence concerns the gene SCT and primary biliary cholangitis.